Navigation Links
Exiqon Diagnostics Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists
Date:5/29/2009

TUSTIN, Calif., May 29 /PRNewswire/ -- Exiqon Diagnostics, announced today a strategic commercial partnership with MedTrust Online, an innovative, comprehensive internet based solution provider for oncologists that offers clinically useful knowledge on the latest topics in cancer treatment. Exiqon Diagnostics, a leader in individualizing cancer care through novel molecular and cell-based (the Oncotech EDR(R) Assay) clinical laboratory services, will become a content partner by providing a comprehensive suite of oncology molecular diagnostics services to MedTrust Online's Oncocentric oncology portal.

MedTrust Online will add Exiqon Diagnostics service offerings, extensive clinical studies, insurance/billing information, order forms, and live forum case studies available to MedTrust's growing oncology health care provider user base consisting of thousands of medical, gynecologic and surgical oncologists as well as pathologists and support staff nationwide.

"We are pleased to add Exiqon Diagnostics to the growing list of molecular diagnostic companies providing content on the MedTrust Online oncology portal," said Matt Sargent, Vice President of Molecular Diagnostics for MedTrust Online. "Molecular diagnostic testing options and drug reimbursement data are the two most heavily requested topics from our oncology user base. Our Oncocentric portal allows oncologists to rapidly find the information that they need on new molecular diagnostics to better practice personalized medicine."

"Partnering with MedTrust offers a unique opportunity to present molecular and cell-based testing options and information to medical oncologists in an unbiased and confidential forum," stated Erik Holmlin, Chief Commercial Officer of Exiqon. "We believe MedTrust can provide patient care teams with important testing information that will help them make better informed and individualized treatment decisions for their patients."

'/>"/>
SOURCE MedTrust Online
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S
2. Exiqon Announces Positive Clinical Data From EORTC Clinical Trial Showing Oncotech EDR Assay Predicts Resistance to Platinum-Based Therapy in Ovarian Cancer
3. Exiqon A/S Announces U.S. Subsidiary Name Change From Oncotech, Inc. to Exiqon Diagnostics, Inc.
4. Exiqon A/S Today Announces a Grant of License to Roche Diagnostics
5. Report Regarding the Managements and Closely Related Parties Transactions With Securities in Exiqon A/S
6. Exiqon A/S: Interim Report for the Period 1 January - 30 June 2008 (Unaudited)
7. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
8. Exiqon Appoints Cynthia French as Chief Scientific Officer and Erik Holmlin as Chief Commercial Officer
9. Exiqon: Major Shareholder Announcement
10. Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting
11. ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax(TM) with novel MRI Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2015)... ... ... For many years, metal-on-quartz filters were the industry standard for the calibration ... Cary 4000-7000, a Perkin Elmer 800-1100 or a Shimadzu 3600-3700, these filters would work ... their SRM-2031 series going back for many years. Unfortunately, these standards remained unusable for ...
(Date:7/3/2015)... , July 3, 2015 /PRNewswire/ ... hakea verkossa osoitteessa  http://www.openinnovationinscience.at ... Innovation in Science" -jatkokoulutusohjelmaan 22.7.2015 ... Gesellschaftin (LBG) tekemän, kansainvälisiä tutkijoita ... terveystieteiden kaksi suurinta haastetta ovat ...
(Date:7/3/2015)... ... ... global failure analysis market is expected to reach $7,147.0 million by 2020, at a ... at the highest CAGR of 8.46%; its growth is expected to be driven by ... for root cause analysis of failure. The market based on the geographic regions has ...
(Date:7/3/2015)... , July 3, 2015 ... "Lab for Open Innovation in Science", som ... . Søknadene sendes på nett, på  http://www.openinnovationinscience.at ... september 2015.  De to største ... til å undersøke nye forskningsspørsmål og kompleksiteten ...
Breaking Biology Technology:FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 2FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 3Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 4Failure Analysis Market to Grow at 7.52% CAGR to 2020 5Lansering av verdens første Open Innovation-program for utdanning av forskere 2Lansering av verdens første Open Innovation-program for utdanning av forskere 3
... , , SOUTHAMPTON, Pa., Jan. 11 Argyce ... http://www.genaera.com , will divest the remaining drug development program ... Trust is soliciting bids to be received no later than ... separately or in combination. Any person interested in purchasing the ...
... BOSTON, Jan. 11 PAREXEL International Corporation (Nasdaq: PRXL ... quarter of Fiscal Year 2010 ended December 31, 2009, and ... The Company,s updated financial guidance takes into account the ... revised expectations for the amount and timing of a previously ...
... ... Screening analysis. , ... 11, 2010 -- Genedata, a leading provider of advanced software solutions for drug discovery and ... has experienced unprecedented industry adoption with 7 out of the 25 leading pharmaceutical companies ...
Cached Biology Technology:Genaera Liquidating Trust To Sell Remaining Proprietary Assets 2PAREXEL Issues Updated Financial And Operational Information 2PAREXEL Issues Updated Financial And Operational Information 3PAREXEL Issues Updated Financial And Operational Information 4PAREXEL Issues Updated Financial And Operational Information 5Genedata at HCA Announces Banner Year for Genedata Screener at Leading Pharmaceutical Companies 2Genedata at HCA Announces Banner Year for Genedata Screener at Leading Pharmaceutical Companies 3
(Date:7/2/2015)... , June 25, 2015 ... addition of the "Next Generation Biometrics Market by ... 2020" report to their offering. The ... Billion by 2020, at a CAGR of 17.9% between ... the leading application for the market. Safran SA ...
(Date:6/30/2015)... To bolster its efforts and commitment to fighting ... the addition of two new team members. ... David Raviv will act as head of strategic ... to providing the most secure solutions for the enterprise market. ... 7 Technologies, a provider of security and management products, which ...
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Latin America Biomedical Sensors Market Report 2015-2020 2
... to Presenilin 2 Alzheimer's disease (AD) ... disease carry mutations in the presenilin proteins ... (APP). These disease-linked mutations result in increased ... (main component of amyloid deposits found in ...
One-step, microplate or cuvet, colorimetric, linear detection range 0.7 mg/dL to 35 mg/dL. Procedure: 5 min....
One-step, microplate or cuvet, colorimetric, linear detection range 0.9 mg/dL to 200 mg/dL. Procedure: 2 min....
[5,6,8,9,12,14,15(n)-3H]Prostaglandin D2, 925 kBq, 25 uCi. Methanol:water:acetonitrile (3:2:1) solution.> 3.0 TBq/mmol, > 80 Ci/mmol.3.7 MBq/ml, 100 uCi/ml. Category: Radiochemicals &Radiation Safety...
Biology Products: